Close Menu

Advances in Spatial Genomics

SkylineDx said that the firms will work together to develop predictive immunological signatures for BioInvent's lead therapy candidate.

Researchers have identified immune cell gene expression signatures that could one day be developed into tests to predict response to treatment.